Medicale Corp. financial data

Symbol
MCLE on OTC
Location
9314 Forest Hill Blvd, #929, Wellington, FL
State of incorporation
NV
Fiscal year end
September 30
Latest financial report
10-Q/A - Q4 2024 - Feb 20, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0.98 % +50.7%
Debt-to-equity -100 %
Return On Equity 60.4 % -54.5%
Return On Assets -35K % -15.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.92M shares 0%
Common Stock, Shares, Outstanding 5.92M shares 0%
Entity Public Float 0 USD
Common Stock, Value, Issued 592 USD 0%
Weighted Average Number of Shares Outstanding, Basic 5.92M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 5.92M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 50.4K USD +4.58%
Operating Income (Loss) -50.4K USD -4.58%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -58.2K USD -54.9%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -55.6K USD -15.4%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 159 USD 0%
Assets 159 USD 0%
Accounts Payable, Current 995 USD
Accrued Liabilities, Current 5.19K USD
Liabilities, Current 22.2K USD +84.9%
Liabilities 116K USD +92.4%
Retained Earnings (Accumulated Deficit) -193K USD -40.6%
Stockholders' Equity Attributable to Parent -116K USD -92.6%
Liabilities and Equity 159 USD 0%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10K USD +63.9%
Net Cash Provided by (Used in) Financing Activities 10K USD -63.9%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 5.92M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 159 USD 0%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 36.9K USD +49.5%
Deferred Tax Assets, Operating Loss Carryforwards 36.9K USD +49.5%
Additional Paid in Capital 76.3K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD